Cloning and Functional Characterization of HDAC11, a Novel Member of the Human Histone Deacetylase Family
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
We have cloned and characterized a human cDNA that belongs to the histone deacetylase family, which we designate as HDAC11. The predicted HDAC11 amino acid sequence reveals an open reading frame of 347 residues with a corresponding molecular mass of 39 kDa. Sequence analyses of the putative HDAC11 protein indicate that it contains conserved residues in the catalytic core regions shared by both class I and II mammalian HDAC enzymes. Putative orthologues of HDAC11 exist in primate, mouse, Drosophila, and plant. Epitope-tagged HDAC11 protein expressed in mammalian cells displays histone deacetylase activity in vitro. Furthermore, HDAC11's enzymatic activity is inhibited by trapoxin, a known histone deacetylase inhibitor. Multiple tissue Northern blot and real-time PCR experiments show that the high expression level of HDAC11 transcripts is limited to kidney, heart, brain, skeletal muscle, and testis. Epitope-tagged HDAC11 protein localizes predominantly to the cell nucleus. Co-immunoprecipitation experiments indicate that HDAC11 may be present in protein complexes that also contain HDAC6. These results indicate that HDAC11 is a novel and unique member of the histone deacetylase family and it may have distinct physiological roles from those of the known HDACs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Two related classes of eukaryotic zinc-containing HDACs have been recognized based upon sequence similarity: class I (HDAC1, 2, 3, and 8) and class II (HDAC4, 5, 6, 7, 9, and 10) (Johnstone, 2002; Gao et al., 2002).”
From Structural Snapshots of Human HDAC8 Provide Insights into the Class I Histone Deacetylases (2004) · cites this paper as Gao et al., 2002
In the citing paper
“It has been shown to associate with HDAC6 (Gao et al., 2002; Cheng et al., 2014)”
From Histone deacetylase 11 is an ε-N-Myristoyllysine hydrolase (2018) · cites this paper as Gao et al., 2002
In the citing paper
“HDAC11 is a newly identified member of the HDAC family and thus far no known physiological function for HDAC11 has been demonstrated23.”
From The histone deacetylase HDAC11 regulates the expression of interleukin 10 and immune tolerance (2009) · cites this paper as [23]
Citations
Cites
Crystal structure of the nucleosome core particle at 2.8 Å resolution
Luger, K., Mäder, A. W., Richmond, R. K., Sargent, D. F., & Richmond, T. J. (1997) · Nature · doi:10.1038/38444 · Cited by 9,466
Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase
Imai, S.-I., Armstrong, C. M., Kaeberlein, M., & Guarente, L. (2000) · Nature · doi:10.1038/35001622 · Cited by 3,510
Roth, S. Y., Denu, J. M., & Allis, C. D. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.81 · Cited by 1,845
A Mammalian Histone Deacetylase Related to the Yeast Transcriptional Regulator Rpd3p
Taunton, J., Hassig, C. A., & Schreiber, S. L. (1996) · Science · doi:10.1126/science.272.5260.408 · Cited by 1,829
Histone acetylation and transcriptional regulatory mechanisms
Struhl, K. (1998) · Genes & Development · doi:10.1101/gad.12.5.599 · Cited by 1,815
Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors
Finnin, M. S., Donigian, J. R., Cohen, A., Richon, V. M., Rifkind, R. A., Marks, P. A., Breslow, R., & Pavletich, N. P. (1999) · Nature · doi:10.1038/43710 · Cited by 1,714
Nuclear Receptor Repression Mediated by a Complex Containing SMRT, mSin3A, and Histone Deacetylase
Nagy, L., Kao, H.-Y., Chakravarti, D., Lin, R. J., Hassig, C. A., Ayer, D. E., Schreiber, S. L., & Evans, R. M. (1997) · Cell · doi:10.1016/s0092-8674(00)80218-4 · Cited by 1,230
Duration of Nuclear NF-κB Action Regulated by Reversible Acetylation
Chen, L.-F., Fischle, W., Verdin, E., & Greene, W. C. (2001) · Science · doi:10.1126/science.1062374 · Cited by 1,222
Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation
McKinsey, T. A., Zhang, C.-L., Lu, J., & Olson, E. N. (2000) · Nature · doi:10.1038/35040593 · Cited by 1,052
Deacetylation of p53 modulates its effect on cell growth and apoptosis
Luo, J., Su, F., Chen, D., Shiloh, A., & Gu, W. (2000) · Nature · doi:10.1038/35042612 · Cited by 818
Research works printed but not linked: 2
- Van Lint, 1996, Gene Expr., 5, 245
- Fischle, 2001, Biochem. Cell Biol., 79, 337, 10.1139/o01-116 · DOI · Paper page
Cited by
Items 701–761 of 761
Clinical Significance of Histone Deacetylase Inhibitors in Cancer
Shankar, S., & Srivastava, R. K. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-200-7_15
ETUDE DE LA DEACETYLASE HDAC6 : UNE ENZYME MULTIFONCTIONNELLE
Gilquin, B. (2005) · OpenGrey (Institut de l'Information Scientifique et Technique)
Toma, G. A., Karapetian, E., Massa, C., Quandt, D., & Seliger, B. (2022) · Figshare · doi:10.6084/m9.figshare.21622061
Yang, Y., Wang, J., Wu, Q., Wang, Y., Meng, H., Zeng, L., Qiu, T. A., Zhao, H., Hu, Q., Weng, Q., et al. (2026) · Clinical Epigenetics · doi:10.1186/s13148-026-02050-y · Cited by 1
“The catalytic core region of HDAC11 contains all of the conserved active site residues found in eukaryotic HDAC proteins [10].”
The role and mechanism of histone deacetylase in COPD
Tang, H., Gao, Q., & Shu, X. (2026) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-026-05503-3
HDAC11 Regulates RNA Splicing via De-Fatty Acylation of SF3B2Preprint
Clements, J., Jung, S. Y., Cao, J., Sun, L., Ghezzi, A. C., Gaylen, M., Reid, L., & Peng, C. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.22.707301
“SF3B2 is nuclear localized, and HDAC11 has been observed in both the nucleus and cytoplasm 17,25,26 .”
Linarès, A. (2011) · theses.fr (ABES) · doi:10.70675/b58d4038z85d2z4a6fza2b6z64e5e5b158c3
Régulation épigénétique du gène CFTR
Bergougnoux, A. (2013) · theses.fr (ABES) · doi:10.70675/96be3b9czbd0az4803za18ez9f92e5e10e5c
Bahhaj, F. E. (2014) · theses.fr (ABES) · doi:10.70675/3f140dd9z5f61z450az82ebz6ce2a732ee06
Etude structurale du complexe de remodelage de la chromatine NuRD et sa sous-unité MBD3 liée à l'ADN
Tabaroni, R. (2018) · theses.fr (ABES) · doi:10.70675/7ad702abz74c7z45a9z9ecdz6aff4ba871ad
“C’est également l’une des dernières HDAC identifiée en 2002 and elle n’a été que faiblement caractérisée (Gao et al., 2002).”
Rifai, K. T. (2018) · theses.fr (ABES) · doi:10.70675/a04ac311z8c0az40fbzad86za9e08d080879
“Yi et al. reported that SIRT1 activation by a SIRT1 specific activator YK-3-237, induces the deacetylation of mt-p53, the oncogenic mutant form of p53, Deacetylation of mt-p53 upregulates the expression of wild-type p53-targets the PUMA and NOXA pro-apoptotic genes, suppressing cell proliferation and arresting cell gr…”
BackgroundInfluentialMéthylation de H3K27 : régulation et rôle dans le cartilage articulaire
Allas, L. (2019) · theses.fr (ABES) · doi:10.70675/0b801552z0546z4765za411z263c0baf83ef
Rôle de l'histone désacétylase HDAC6 au cours de l'érythropoïèse humaine
Vong, P. (2022) · theses.fr (ABES) · doi:10.70675/699e8d9bz5404z43f6zabe7zdd0f0b6c8c42
Ramos‐Morales, E. (2021) · theses.fr (ABES) · doi:10.70675/c6b28473zf6b6z4024z99bfz05629f0484d7
Lun, L., Lian, X., Wang, W., Yuan, P., Zuo, J., Wang, J., Wang, L., & Song, L. (2026) · Comparative Immunology Reports · doi:10.1016/j.cirep.2026.200280
“HDAC11 is the only member of class IV identified in mammals, and has sequence homology with the catalytic domains of both class I and II HDACs [3].”
InfluentialDash, S., Shehensha, S., Dhar, A. K., Kandula, D. R., & Gorti, S. K. K. (2026) · Future Medicinal Chemistry · doi:10.1080/17568919.2026.2675978
Critical structural features of HDAC11 inhibitors
Dasgupta, I., Sinha, S., & Gayen, S. (2026) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2026.05.045
HDAC11 as a potential therapeutic target for Alzheimer’s disease
Zhang, W., Wang, Y., Tocci, D. R., Wang, C., & Zhang, C. M. (2026) · Drug Discovery Today · doi:10.1016/j.drudis.2026.104730 · Cited by 1
Distillation enables scalable high-fidelity virtual screening across ultra-large chemical librariesPreprint
Dai, J., Wang, Y., Shan, N. L., Mariani, M., Yu, Z., Yan, Q., Golani, L. K., Surovtseva, Y. V., Lee, H., & Pusztai, L. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.29.735361
“The docking grid box was set to 20 × 20 × 20 ų, with exhaustiveness = 32.”
Dual HDAC/PI3K inhibitors as a potential and emerging cancer therapy: a review
Madhukumari, Akshatha, H. S., Nair, S. P., Arun Kumar, S., Bidye, D. P., & Pujar, G. V. (2026) · Future Medicinal Chemistry · doi:10.1080/17568919.2026.2699690 · Cited by 2
Treating neurological diseases through epigenetic inhibition: A neuroepigenetic therapy hypothesis
Reddy, D. S., Franklin, L., Golub, V. M., Desai, H., & Ramakrishnan, S. (2026) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/j.jpet.2026.105019 · Cited by 1
Maiti, K., Chakraborty, D., Ponnusamy, C. S., Gnanasekar, H., Ravindran, N., Sridharan, B., & Velusamy, M. (2026) · Journal of Molecular Modeling · doi:10.1007/s00894-026-06893-3
“It is expressed in muscle, heart, kidney, and brain, with enhanced expression in the gallbladder [28, 29].”
Lv, Z., Li, Q., & Feng, X. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1981328
Vošahlíková, M., Kutil, Z., Kudlacova, J., Havlínová, B., Meleshin, M., Nováková, Z., Šnajdr, I., Schutkowski, M., & Bařinka, C. (2026) · ACS Chemical Biology · doi:10.1021/acschembio.6c00703
Yang, X., Li, X., Huang, R., Zhou, Y., Li, H., Yao, P., Hu, Y., Liu, Y., Wang, C., & Bai, P. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6c01054
Wang, W., Yang, X., Yang, Y., Zhou, Y., Yao, P., Shu, Z., Li, T., Gao, M., Wang, C., & Bai, P. (2026) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2026.119430
BindingDB Entry 50011516: Recent advances in the discovery of potent and selective HDAC6 inhibitors.
BindingDB (2022) · UC San Diego · doi:10.7270/q25h7kv7
BindingDB (2010) · UC San Diego · doi:10.7270/q2mp5398
BindingDB (2026) · UC San Diego · doi:10.7270/q2b85dzw
BindingDB (2020) · UC San Diego · doi:10.7270/q2jd50d0
BindingDB Entry 50032567: Inhibitors selective for HDAC6 in enzymes and cells.
BindingDB (2011) · UC San Diego · doi:10.7270/q2fn16fw
BindingDB (2017) · UC San Diego · doi:10.7270/q27m09s1
BindingDB (2016) · UC San Diego · doi:10.7270/q2j67jg6
BindingDB Entry 50033283: Discovery of histone deacetylase 8 selective inhibitors.
BindingDB (2011) · UC San Diego · doi:10.7270/q2zc835m
BindingDB Entry 50000223: Stabilizing HDAC11 with SAHA to assay slow-binding benzamide inhibitors.
BindingDB (2019) · UC San Diego · doi:10.7270/q2n018zr
BindingDB (2016) · UC San Diego · doi:10.7270/q2d50ksd
Barry, P. L., Alagiyawanna, D. M., Werder, R. B., Faux, M. C., & Eisenstat, D. D. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1962790
Enzymatic Mechanisms and Chemical Probes of the Myst Family of Histone Acetyltransferases
Yang, C. (2013) · Digital Archive @ GSU · doi:10.57709/4313955 · Cited by 1
Histone Deacetylase Inhibitors and Innate Immunity in Septic Shock
Bertsche, J. (2009) · VCU Scholars Compass (Virginia Commonwealth University) · doi:10.25772/6ce7-qj91
“Class IV consists of only HDAC 11.(52) Class I HDACs are thought to be primarily localized in the nucleus, whereas class II HDACs shuttle”
BackgroundNielsen, T. K. (2005) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-612
Modulation of apoptosis and signalling in cancer cells after treatment with epigenetic modulators
Palani, R. N., & Devi, C. P. A. (2012) · Common Library Network (Der Gemeinsame Bibliotheksverbund)
Metadata
- Authors
- Gao, L., Cueto, M. A., Asselbergs, F., & Atadja, P.
- Affiliations
- Novartis (United States) (US)
- Corresponding author
- Atadja, Peter
- ORCID
- Gao, Lin
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2002-07
- Volume
- 277
- Issue
- 28
- Pages
- 25748-25755
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2070089404
- Cited by
- 744
- References
- 43
- Citations by year
- 2026: 27 · 2025: 28 · 2024: 32 · 2023: 36 · 2022: 31 · 2021: 33 · 2020: 43 · 2019: 26 · 2018: 30 · 2017: 36 · 2016: 30 · 2015: 41 · 2014: 34 · 2013: 30 · 2012: 37
- FWCI
- 8.48
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6687 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Keywords
- HDAC11, histone deacetylase, cDNA cloning, histone deacetylase activity, tissue expression, nuclear localization, protein complexes, evolutionary conservation
- MeSH terms
- Amino Acid Sequence, Animals, Base Sequence, Cloning, Molecular, Histone Deacetylases, Humans, Molecular Sequence Data, Nuclear Proteins, RNA, Messenger, Sequence Homology, Amino Acid, DNA, Complementary
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.